NasdaqGS - Nasdaq Real Time Price USD

Biomea Fusion, Inc. (BMEA)

Compare
5.85 +0.21 (+3.72%)
At close: 4:00:01 PM EST
6.25 +0.40 (+6.84%)
After hours: 6:32:58 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
151,324.00
126,135.00
83,634.00
41,667.00
5,327.00
Operating Income
-151,324.00
-126,135.00
-83,634.00
-41,667.00
-5,327.00
Net Non Operating Interest Income Expense
7,316.00
8,880.00
1,806.00
100.00
3.00
Other Income Expense
--
--
--
--
3.00
Pretax Income
-144,008.00
-117,255.00
-81,828.00
-41,567.00
-5,324.00
Net Income Common Stockholders
-144,008.00
-117,255.00
-81,828.00
-41,567.00
-5,324.00
Diluted NI Available to Com Stockholders
-144,008.00
-117,255.00
-81,828.00
-41,567.00
-5,324.00
Basic EPS
-4.01
-3.44
-2.80
-1.74
-0.50
Diluted EPS
-4.01
-3.44
-2.80
-1.74
-0.50
Basic Average Shares
35,982.20
34,106.92
29,271.78
23,858.55
10,708.05
Diluted Average Shares
35,982.20
34,106.92
29,271.78
23,858.55
10,708.05
Total Operating Income as Reported
-151,324.00
-126,135.00
-83,634.00
-41,667.00
-5,327.00
Total Expenses
151,324.00
126,135.00
83,634.00
41,667.00
5,327.00
Net Income from Continuing & Discontinued Operation
-144,008.00
-117,255.00
-81,828.00
-41,567.00
-5,324.00
Normalized Income
-144,008.00
-117,255.00
-81,828.00
-41,567.00
-5,324.00
Interest Income
7,316.00
8,880.00
1,806.00
100.00
3.00
Net Interest Income
7,316.00
8,880.00
1,806.00
100.00
3.00
EBIT
-151,324.00
-126,135.00
-83,634.00
-41,667.00
-5,327.00
EBITDA
-149,625.00
-124,620.00
-82,943.00
-41,418.00
-5,319.00
Reconciled Depreciation
1,699.00
1,515.00
691.00
249.00
8.00
Net Income from Continuing Operation Net Minority Interest
-144,008.00
-117,255.00
-81,828.00
-41,567.00
-5,324.00
Normalized EBITDA
-149,625.00
-124,620.00
-82,943.00
-41,418.00
-5,319.00
12/31/2020 - 4/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANAB AnaptysBio, Inc.
16.65
+6.80%
 
NMRA Neumora Therapeutics, Inc.
10.87
+5.33%
 
NRIX Nurix Therapeutics, Inc.
20.81
+2.66%
 
RLAY Relay Therapeutics, Inc.
4.8400
+2.76%
 
SLRN Acelyrin, Inc.
3.3700
+4.33%
 
RPTX Repare Therapeutics Inc.
1.6000
-9.60%
 
AFMD Affimed N.V.
2.1300
-0.93%
 
EWTX Edgewise Therapeutics, Inc.
32.69
+18.36%
 
ENTA Enanta Pharmaceuticals, Inc.
6.31
+4.64%
 
OLMA Olema Pharmaceuticals, Inc.
6.44
-4.59%